Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency

S. J. Enna; J. P. Bennett; D. R. Burt; I. Creese; Solomon H. Snyder

doi:10.1038/263338a0

Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency

S. J. Enna, J. P. Bennett, D. R. Burt, I. Creese, Solomon H. Snyder

School of Medicine

Research output: Contribution to journal › Article › peer-review

92 Scopus citations

Abstract

THE molecular mechanism responsible for the therapeutic activity of a drug is often suggested by the biochemical event which correlates best with clinical potency. Thus, if optical or geometrical isomers of a drug have markedly different clinical potencies, the most relevant biochemical effect should also exhibit isomeric specificity.

Original language	English (US)
Pages (from-to)	338-341
Number of pages	4
Journal	Nature
Volume	263
Issue number	5575
DOIs	https://doi.org/10.1038/263338a0
State	Published - 1976

ASJC Scopus subject areas

General

Access to Document

10.1038/263338a0

Cite this

@article{c4d3ab2eea654a3a840408945aa12c6c,

title = "Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency",

abstract = "THE molecular mechanism responsible for the therapeutic activity of a drug is often suggested by the biochemical event which correlates best with clinical potency. Thus, if optical or geometrical isomers of a drug have markedly different clinical potencies, the most relevant biochemical effect should also exhibit isomeric specificity.",

author = "Enna, {S. J.} and Bennett, {J. P.} and Burt, {D. R.} and I. Creese and Snyder, {Solomon H.}",

year = "1976",

doi = "10.1038/263338a0",

language = "English (US)",

volume = "263",

pages = "338--341",

journal = "Nature",

issn = "0028-0836",

publisher = "Nature Publishing Group",

number = "5575",

}

TY - JOUR

T1 - Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency

AU - Enna, S. J.

AU - Bennett, J. P.

AU - Burt, D. R.

AU - Creese, I.

AU - Snyder, Solomon H.

PY - 1976

Y1 - 1976

N2 - THE molecular mechanism responsible for the therapeutic activity of a drug is often suggested by the biochemical event which correlates best with clinical potency. Thus, if optical or geometrical isomers of a drug have markedly different clinical potencies, the most relevant biochemical effect should also exhibit isomeric specificity.

AB - THE molecular mechanism responsible for the therapeutic activity of a drug is often suggested by the biochemical event which correlates best with clinical potency. Thus, if optical or geometrical isomers of a drug have markedly different clinical potencies, the most relevant biochemical effect should also exhibit isomeric specificity.

UR - http://www.scopus.com/inward/record.url?scp=0017085848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017085848&partnerID=8YFLogxK

U2 - 10.1038/263338a0

DO - 10.1038/263338a0

M3 - Article

C2 - 8733

AN - SCOPUS:0017085848

SN - 0028-0836

VL - 263

SP - 338

EP - 341

JO - Nature

JF - Nature

IS - 5575

ER -

Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this